The absolute bioavailability following intramuscular injection was found to be approximately 1419% in rats and 4551% in beagle dogs, indicating variable absorption depending on the species and administration route
After the procedure, a mixture of Neosporin and 5% topical lidocaine ointment was applied to the treated areas to promote healing and manage discomfort
The advantage of this type of compounds, apart from the reduction in side effects, is their efficient metabolism to non-toxic products and a high affinity for specific molecular targets, which can potentially be associated with enhanced treatment efficacy, enabling the use of a relatively low dose to produce identical biological effects [3]
The MHRA ( Medicines and Healthcare products Regulatory Agency ) has two main application procedures: Simple Reclassification : This is a straightforward and quick procedure based on an analogous product (a medicinal product already on the UK market with the same active ingredient, route of administration, use, and a similar or higher strength/dosage)